with Matthew W. Johnson, Ph.D.

Part of the 16th annual Horizons: Perspectives on Psychedelics conference in New York City.

Wednesday, May 8, 2023, 8am-6pm
at the New York Academy of Medicine

This course will focus on the treatment of addictions with psychedelics. We will cover historical and modern research suggesting anti-addiction treatment efficacy for psychedelic compounds. We will review psychotherapeutic modalities used to facilitate psychedelic treatment of addiction (e.g., cognitive behavioral therapy). Methods for ensuring safety and maximizing efficacy will be explored. We will also explore future directions for the future of psychedelic compounds in the treatment of addictions.

The Instructors

Matthew is The Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins. He has published research on psychedelics and mystical experience, personality change, tobacco smoking cessation, cancer distress treatment, and depression treatment. In 2021 he received as principal investigator the first grant in 50 years from the US government for a treatment study with a classic psychedelic, specifically psilocybin in treatment of tobacco addiction. He is also known for his expertise in behavioral economics, addiction, sexual risk behavior, and research with a wide variety of drug classes. 

The New York Academy of Medicine

1216 5th Ave, New York, NY 10029

Since its founding in 1847, the Academy has been a vital source for thought and action regarding healthcare and public health in New York City and beyond. 

Its landmarked building on Fifth Avenue facing Central Park was completed in 1927 and houses one of the most comprehensive and historic medical libraries in the country.

Horizons offers all-day introductions to psychedelic-assisted therapy led by leading researchers and experienced practitioners. These classes are designed with medical and mental health professionals and students in mind, but may also be attended by others. These classes are limited in size, not recorded or broadcast, and are intended to foster interaction between the students and instructors. The class is one full day of instruction with breaks in mid-morning, midday, and late afternoon.

Lunch is available at The New York Academy of Medicine for an additional fee, available through registration.

8:00am | Doors open
9:00am | Convene
9:30am | Morning session
1:00pm | Lunch
2:00pm | Reconvene
2:15pm | Afternoon session
5:15pm | Session concludes
6:00pm | Adjourn

Registering for catered lunch on-site is strongly recommended, as neighborhood lunch options are limited.

Due to changes in CE / CME requirements and providers, Horizons will not be offering CE / CME credits for any workshops or presentations.

Scholarships

Our scholarship programs allows community members to attend who may not have the resources to support our standard rates.

The scholarship program is available to anyone, not just students and academic professionals.

Applications for this year's scholarships will open shortly.

Learn more >

This workshop will encompass:

1. Describe psychedelic-assisted psychotherapy, and how it differs from typical psychotherapy and other psychiatric approaches
2. Identify the personal/professional qualities and environmental precautions that appear to enhance safety and efficacy in treatments that employ psychedelic substances
3. Describe research to date on using psychedelic-assisted psychotherapy for the treatment of substance use disorders
   

Matthew W. Johnson, Ph.D

Psychedelic scientist and psychologist, Johns Hopkins University

Matthew W. Johnson, Ph.D., is The Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins. Working with psychedelics since 2004, he is one of the world’s most widely published experts on psychedelics. He has published research on psychedelics and mystical experience, personality change, tobacco smoking cessation, cancer distress treatment, and depression treatment. In 2021 he received as principal investigator the first grant in 50 years from the US government for a treatment study with a classic psychedelic, specifically psilocybin in treatment of tobacco addiction. He is also known for his expertise in behavioral economics, addiction, sexual risk behavior, and research with a wide variety of drug classes. He’s been Interviewed by Anderson Cooper on 60 Minutes, the New York Times, the Washington Post, the Wall Street Journal, CNN, NPR, Fox News, Fox Business News, BBC and in Michael Pollan’s book How to Change Your Mind.